Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
(COV) stock logo
COV
(COV)
$0.00
$65.97
$108.57
N/AN/A3.88 million shsN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$0.34
-2.9%
C$0.38
C$0.23
C$0.47
C$45.74M0.2871,446 shs44,286 shs
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.20
+0.2%
$11.10
$10.52
$11.92
$241.72M-0.0149,173 shs98,478 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
(COV) stock logo
COV
(COV)
0.00%0.00%0.00%0.00%0.00%
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
-1.47%-4.29%-9.46%-18.29%-12.99%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
+0.18%+0.27%+0.90%+1.63%+6.46%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
(COV) stock logo
COV
(COV)
N/AN/AN/AN/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
(COV) stock logo
COV
(COV)
N/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
3.00
BuyN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
(COV) stock logo
COV
(COV)
N/AN/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$22.42M2.04C$0.08 per share4.13C$0.20 per share1.68
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/A$0.40 per share28.09($0.64) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
(COV) stock logo
COV
(COV)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
C$3.72MC$0.0311.17N/A16.57%14.66%1.87%5/9/2024 (Estimated)
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.44MN/A0.00N/AN/A-65.59%5.02%N/A

Latest HVO, RENE, COV, and MBX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/14/2024Q1 2024
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AC$0.02+C$0.02C$0.02C$8.10 millionC$8.41 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
(COV) stock logo
COV
(COV)
N/AN/AN/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
(COV) stock logo
COV
(COV)
N/AN/AN/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
24.53
8.53
5.57
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A
0.22
0.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
(COV) stock logo
COV
(COV)
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
0.42%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
58.96%

Insider Ownership

CompanyInsider Ownership
(COV) stock logo
COV
(COV)
N/A
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
14.07%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
20.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
(COV) stock logo
COV
(COV)
N/AN/AN/ANot Optionable
Microbix Biosystems Inc. stock logo
MBX
Microbix Biosystems
N/A136.55 millionN/ANot Optionable
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A21.62 million17.30 millionNot Optionable

HVO, RENE, COV, and MBX Headlines

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

(COV) logo

(COV)

NYSE:COV
Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.
Microbix Biosystems logo

Microbix Biosystems

TSE:MBX
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Cartesian Growth Co. II logo

Cartesian Growth Co. II

NASDAQ:RENE
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.